Unravelling reimbursement and HTA issues for drug/device combinations and companion diagnostics
5 December 2012. How do payers respond to the reimbursement issues that arise with companion diagnostics and drug/device combinations, where two products that span two different reimbursement channels are used together? This is the challenging issue tackled in this article.
Download This Publication